Triamist 55 μg Nasal Spray
PDF Leaflet Revision Date: 31 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Preventative treatment of seasonal and perennial allergic rhinitis.
Dosage (summary)
Adults: 220 u03bcg (2 sprays in each nostril once daily); Children 6-12 years: 110 u03bcg (1 spray in each nostril daily).
Onset of Action / Duration
Onset: 3-4 days, Duration: up to 24 hours
Special Populations
- Children under 6 years
- Patients on corticosteroids
Pregnancy & Breastfeeding
Not recommended during pregnancy; safety during lactation not established.
Key Drug Interactions
- Increased risk of adrenal suppression with oral corticosteroids
Contraindications
- Hypersensitivity to triamcinolone
- Children under 6 years
Common side effects
- Headache
- Rhinitis
- Pharyngitis
- Nasal irritation
- Nasal candidiasis
Counselling Points
- Shake well before use
- Do not exceed prescribed dosage
- Monitor for signs of adrenal insufficiency
Serious warnings
- Potential for growth suppression in children
- Caution in patients with infections
Important Disclaimer
The Triamist 55 μg Nasal Spray professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
